Maria Grazia Roncarolo

Maria Grazia Roncarolo (born 17 December 1954) is an Italian pediatrician who is currently George D. Smith Professor in Stem Cell and Regenerative Medicine and Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) at Stanford University. She is also the Director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine along with Irving Weissman and Michael Longaker and the Director for Center for Definitive and Curative Medicine at Stanford.

She was educated at the University of Turin. She is a past President of the Federation of Clinical Immunology Societies, and is a member of the Austrian Academy of Sciences. She is an academic founder of Graphite Bio. She has an h-index of 91. Provided by Wikipedia
Showing 1 - 17 results of 17 for search 'Maria-Grazia Roncarolo', query time: 0.05s Refine Results
  1. 1
    Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation

    Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation by Alice Bertaina, Maria Grazia Roncarolo, Maria Grazia Roncarolo

    Published 2019-07-01
    Get full text
    Article
  2. 2
    Type 1 regulatory T cell-mediated tolerance in health and disease

    Type 1 regulatory T cell-mediated tolerance in health and disease by Robert A. Freeborn, Steven Strubbe, Maria Grazia Roncarolo, Maria Grazia Roncarolo, Maria Grazia Roncarolo

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Engineered T Regulatory Type 1 Cells for Clinical Application

    Engineered T Regulatory Type 1 Cells for Clinical Application by Silvia Gregori, Maria Grazia Roncarolo

    Published 2018-02-01
    Get full text
    Article
  4. 4
    Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products

    Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products by Alessandro Aiuti, Maria Grazia Roncarolo, Luigi Naldini

    Published 2017-04-01
    Get full text
    Article
  5. 5
    From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases

    From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases by Yannick Bulliard, Robert Freeborn, Molly Javier Uyeda, Daryl Humes, Ryan Bjordahl, David de Vries, Maria Grazia Roncarolo, Maria Grazia Roncarolo

    Published 2024-12-01
    Get full text
    Article
  6. 6
    A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products

    A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products by Yohei Sato, Abinaya Nathan, Suzette Shipp, John Fraser Wright, Keri Marie Tate, Prachi Wani, Maria-Grazia Roncarolo, Rosa Bacchetta

    Published 2024-03-01
    Get full text
    Article
  7. 7
    A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products

    A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products by Yohei Sato, Abinaya Nathan, Suzette Shipp, John Fraser Wright, Keri Marie Tate, Prachi Wani, Maria-Grazia Roncarolo, Rosa Bacchetta

    Published 2023-12-01
    Get full text
    Article
  8. 8
    HLA-G expression levels influence the tolerogenic activity of human DC-10

    HLA-G expression levels influence the tolerogenic activity of human DC-10 by Giada Amodio, Michela Comi, Daniela Tomasoni, Monica Emma Gianolini, Roberta Rizzo, Joël LeMaoult, Maria-Grazia Roncarolo, Silvia Gregori

    Published 2015-04-01
    Get full text
    Article
  9. 9
    Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells

    Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells by Eleonora Tresoldi, Ilaria Dell’Albani, Angela Stabilini, Tatiana Jofra, Andrea Valle, Nicola Gagliani, Attilio Bondanza, Maria Grazia Roncarolo, Manuela Battaglia

    Published 2011-09-01
    Get full text
    Article
  10. 10
    Reply to Comment on “Stability of human rapamycin-expanded CD4+CD25+ T-regulatory cells” Haematologica 2011;96(9):1357–65

    Reply to Comment on “Stability of human rapamycin-expanded CD4+CD25+ T-regulatory cells” Haematologica 2011;96(9):1357–65 by Eleonora Tresoldi, Ilaria Dell’Albani, Angela Stabilini, Tatiana Jofra, Andrea Valle, Nicola Gagliani, Attilio Bondanza, Maria Grazia Roncarolo, Manuela Battaglia

    Published 2012-05-01
    Get full text
    Article
  11. 11
    Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation

    Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell trans... by Volker Wiebking, Ciaran M. Lee, Nathalie Mostrel, Premanjali Lahiri, Rasmus Bak, Gang Bao, Maria Grazia Roncarolo, Alice Bertaina, Matthew H. Porteus

    Published 2020-04-01
    Get full text
    Article
  12. 12
    Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID

    Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID by Caterina Cancrini, Francesca Ferrua, Alessia Scarselli, Immacolata Brigida, Maria Luisa Romiti, Graziano Barera, Andrea Finocchi, Maria Grazia Roncarolo, Maurizio Caniglia, Alessandro Aiuti

    Published 2010-10-01
    Get full text
    Article
  13. 13
    Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice

    Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice by Andrea Annoni, Alessio Cantore, Patrizia Della Valle, Kevin Goudy, Mahzad Akbarpour, Fabio Russo, Sara Bartolaccini, Armando D'Angelo, Maria Grazia Roncarolo, Luigi Naldini

    Published 2013-09-01
    Get full text
    Article
  14. 14
    Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia

    Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia by Giorgia Serafini, Marco Andreani, Manuela Testi, MariaRosa Battarra, Andrea Bontadini, Eika Biral, Katharina Fleischhauer, Sarah Marktel, Guido Lucarelli, Maria Grazia Roncarolo, Rosa Bacchetta

    Published 2009-10-01
    Get full text
    Article
  15. 15
    Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy

    Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy by Rosa Bacchetta, Silvia Gregori, Giorgia Serafini, Claudia Sartirana, Ute Schulz, Elisabetta Zino, Stefan Tomiuk, Uwe Jansen, Maurilio Ponzoni, Carlo Terenzio Paties, Katharina Fleischhauer, Maria Grazia Roncarolo

    Published 2010-12-01
    Get full text
    Article
  16. 16
    Transcriptional and epigenetic characterization of a new in vitro platform to model the formation of human pharyngeal endoderm

    Transcriptional and epigenetic characterization of a new in vitro platform to model the formation of human pharyngeal endoderm by Andrea Cipriano, Alessio Colantoni, Alessandro Calicchio, Jonathan Fiorentino, Danielle Gomes, Mahdi Moqri, Alexander Parker, Sajede Rasouli, Matthew Caldwell, Francesca Briganti, Maria Grazia Roncarolo, Antonio Baldini, Katja G. Weinacht, Gian Gaetano Tartaglia, Vittorio Sebastiano

    Published 2024-08-01
    Get full text
    Article
  17. 17
    Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells

    Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells by Brandon Cieniewicz, Molly Javier Uyeda, Ping (Pauline) Chen, Ece Canan Sayitoglu, Jeffrey Mao-Hwa Liu, Grazia Andolfi, Katharine Greenthal, Alice Bertaina, Silvia Gregori, Rosa Bacchetta, Norman James Lacayo, Alma-Martina Cepika, Maria Grazia Roncarolo

    Published 2020-09-01
    Get full text
    Article

Search Tools: